Relationship Between ABO Blood Group and Clinicopathological Factors and Their Effect on the Survival of Japanese Patients with Esophageal Squamous Cell Carcinoma

Overview

Journal Surg Today

Specialty General Surgery

Date 2016 Dec 29

PMID 28028639

Citations 4

Authors

Fumiaki Shiratori

Hideaki Shimada

Satoshi Yajima

Takashi Suzuki

Yoko Oshima

Tatsuki Nanami

Masaaki Ito

Hironori Kaneko

Affiliations

Soon will be listed here.

Abstract

Purpose: Several studies have evaluated the association between ABO blood group and the prognosis of various types of cancer; however, little is known about the relationship between ABO blood group and esophageal squamous cell carcinoma (SCC). We investigated how ABO blood group and clinicopathological characteristics are related to the survival of Japanese patients with esophageal SCC.

Methods: We reviewed the medical records of 181 patients who underwent surgery for esophageal SCC between June, 2004 and December, 2015 and analyzed the association between ABO blood group and clinicopathological factors. Clinicopathological factors were also evaluated by univariate and multivariate analyses for possible association with survival.

Results: The prevalence of each blood group was as follows: A, 35.5%; B, 22.4%; O, 32.8%; and AB, 8.2%. The 5-year overall survival of all patients was 37.1%. Patients with non-type B blood had significantly worse 5-year overall survival than those with type B blood (30.2 vs. 58.8%, P < 0.05).

Conclusions: ABO blood groups were associated with the survival of Japanese patients with esophageal SCC. Patients with non-B blood groups had significantly worse overall survival than those with the B blood group.

Citing Articles

Preoperative Low Serum Calcium Levels Predict Poor Prognosis for Patients with Esophageal Cancer.

Shiratori F, Suzuki T, Yajima S, Oshima Y, Nanami T, Funahashi K Ann Thorac Cardiovasc Surg. 2021; 28(2):96-102.

PMID: 34556614 PMC: 9081468. DOI: 10.5761/atcs.oa.21-00167.

Prognostic Role of ABO Blood Type in Operable Esophageal Cancer: Analysis of 2179 Southern Chinese Patients.

Zhang S, Jia M, Cai X, Yang W, Liao S, Liu Z Front Oncol. 2021; 10:586084.

PMID: 33392080 PMC: 7775654. DOI: 10.3389/fonc.2020.586084.

Clinical characteristics and survival of 5283 esophageal cancer patients: A multicenter study from eighteen hospitals across six regions in China.

He Y, Liang D, Du L, Guo T, Liu Y, Sun X Cancer Commun (Lond). 2020; 40(10):531-544.

PMID: 32845581 PMC: 7571391. DOI: 10.1002/cac2.12087.

Can 9q34.2 rs633862 polymorphism predict survival in epithelial ovarian cancer?.

Jiang R, Xu Y, Wang P, Cheng X, Shi T, Zang R PeerJ. 2017; 5:e3946.

PMID: 29109911 PMC: 5671115. DOI: 10.7717/peerj.3946.

References

Pare G, Chasman D, Kellogg M, Zee R, Rifai N, Badola S . Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women. PLoS Genet. 2008; 4(7):e1000118. PMC: 2432033. DOI: 10.1371/journal.pgen.1000118. View

Li N, Xu M, Li C, Ou W, Wang B, Zhang S . Prognostic role of the ABO blood types in Chinese patients with curatively resected non-small cell lung cancer: a retrospective analysis of 1601 cases at a single cancer center. Chin J Cancer. 2015; 34(10):475-82. PMC: 4593379. DOI: 10.1186/s40880-015-0054-2. View

Graziano S, Tatum A, Gonchoroff N, Newman N, Kohman L . Blood group antigen A and flow cytometric analysis in resected early-stage non-small cell lung cancer. Clin Cancer Res. 1997; 3(1):87-93. View

Melzer D, Perry J, Hernandez D, Corsi A, Stevens K, Rafferty I . A genome-wide association study identifies protein quantitative trait loci (pQTLs). PLoS Genet. 2008; 4(5):e1000072. PMC: 2362067. DOI: 10.1371/journal.pgen.1000072. View

Nozoe T, Ezaki T, Baba H, Kakeji Y, Maehara Y . Correlation of ABO blood group with clinicopathologic characteristics of patients with esophageal squamous cell carcinoma. Dis Esophagus. 2004; 17(2):146-9. DOI: 10.1111/j.1442-2050.2004.00392.x. View

Qiu M, Zhang D, Ruan D, Luo H, Wang Z, Zhou Z . A relationship between ABO blood groups and clinicopathologic characteristics of patients with gastric adenocarcinoma in China. Med Oncol. 2010; 28 Suppl 1:S268-73. DOI: 10.1007/s12032-010-9735-5. View

Fukumoto K, Taniguchi T, Usami N, Kawaguchi K, Fukui T, Ishiguro F . The ABO blood group is an independent prognostic factor in patients with resected non-small cell lung cancer. J Epidemiol. 2014; 25(2):110-6. PMC: 4310871. DOI: 10.2188/jea.JE20140102. View

Paterson A, Lopes-Virella M, Waggott D, Boright A, Hosseini S, Carter R . Genome-wide association identifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin. Arterioscler Thromb Vasc Biol. 2009; 29(11):1958-67. PMC: 3147250. DOI: 10.1161/ATVBAHA.109.192971. View

Sato E, Maruta K, Yonezawa S, Nakamura T . Blood group H(O) antigen in normal, dysplastic and carcinomatous esophageal epithelium. Gan. 1984; 75(3):223-9. View

10.

Yang X, Huang Y, Feng J . Is there an association between ABO blood group and overall survival in patients with esophageal squamous cell carcinoma?. Int J Clin Exp Med. 2014; 7(8):2214-8. PMC: 4161570. View

11.

Sun P, Chen C, Zhang F, An X, Li X, Li Y . The ABO blood group predicts survival in esophageal squamous cell carcinoma in patients who ever smoked: a retrospective study from China. Tumour Biol. 2014; 35(7):7201-8. DOI: 10.1007/s13277-014-1960-7. View

12.

Suzuki T, Shimada H, Nanami T, Oshima Y, Yajima S, Ito M . Hyperfibrinogenemia is associated with inflammatory mediators and poor prognosis in patients with gastric cancer. Surg Today. 2016; 46(12):1394-1401. DOI: 10.1007/s00595-016-1339-z. View

13.

Xiao S, Feng F, Sun L, Xu G, Lian X, Guo M . [Study on prognosis relationship between ABO blood groups of patients with gastric cancer]. Zhonghua Wei Chang Wai Ke Za Zhi. 2015; 18(10):1011-5. View

14.

Liumbruno G, Franchini M . Hemostasis, cancer, and ABO blood group: the most recent evidence of association. J Thromb Thrombolysis. 2013; 38(2):160-6. DOI: 10.1007/s11239-013-1027-4. View

15.

Xu Y, Jiang T, Cui Y, Zhao Y, Qiu L . Prognostic value of ABO blood group in patients with gastric cancer. J Surg Res. 2016; 201(1):188-95. DOI: 10.1016/j.jss.2015.10.039. View

16.

Yazer M . What a difference 2 nucleotides make: a short review of ABO genetics. Transfus Med Rev. 2005; 19(3):200-9. DOI: 10.1016/j.tmrv.2005.02.003. View

17.

Shimada H, Oohira G, Okazumi S, Matsubara H, Nabeya Y, Hayashi H . Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma. J Am Coll Surg. 2004; 198(5):737-41. DOI: 10.1016/j.jamcollsurg.2004.01.022. View

18.

Unal D, Eroglu C, Kurtul N, Oguz A, Tasdemir A, Kaplan B . ABO blood groups are not associated with treatment response and prognosis in patients with local advanced non- small cell lung cancer. Asian Pac J Cancer Prev. 2013; 14(6):3945-8. DOI: 10.7314/apjcp.2013.14.6.3945. View

19.

Leon-Atance P, Moreno-Mata N, Gonzalez-Aragoneses F, Canizares-Carretero M, Poblet-Martinez E, Genoves-Crespo M . Prognostic influence of loss of blood group A antigen expression in pathologic stage I non-small-cell lung cancer. Arch Bronconeumol. 2011; 48(2):49-54. DOI: 10.1016/j.arbres.2011.10.003. View

20.

Larsen R, Ernst L, Nair R, Lowe J . Molecular cloning, sequence, and expression of a human GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase cDNA that can form the H blood group antigen. Proc Natl Acad Sci U S A. 1990; 87(17):6674-8. PMC: 54599. DOI: 10.1073/pnas.87.17.6674. View